Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...

The American Academy of Pediatrics had earlier urged parents to get young children vaccinated against Covid — pushing back ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...

With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.

The Department of Health and Human Services cut funding for messenger ribonucleic acid vaccine development earlier this month.

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 projected revenue range to $1.5 to $2.2 billion, reflecting a $300 million ...

If Canada is serious about becoming a global powerhouse in fields such as AI and life sciences then this intrapreneur mindset ...